[1]Patent:EP2192109,2010,A1,.Locationinpatent:Page/Pagecolumn45
[1]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-EP2192109,2010,A1Locationinpatent:Page/Pagecolumn52
[2]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-EP2871176,2015,A1Locationinpatent:Paragraph0172-0175
[1]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-EP2192109,2010,A1Locationinpatent:Page/Pagecolumn45
[1]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-EP2871176,2015,A1
[2]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-EP2871176,2015,A1
[3]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-EP2871176,2015,A1
[4]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-EP2871176,2015,A1
[5]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-EP2871176,2015,A1
[6]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-EP2871176,2015,A1
[1]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-EP2871176,2015,A1
[2]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-EP2871176,2015,A1
[3]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-EP2871176,2015,A1
[4]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-EP2871176,2015,A1
[5]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-EP2871176,2015,A1
[1]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-EP2871176,2015,A1Locationinpatent:Paragraph0170;0171
Title: Vinik A, et al. Efficacy and safety of Mirogabalin (DS-5565) for the treatment of diabetic peripheral neuropathic pain: a randomized, double-blind, placebo- and active comparator-controlled, adaptive proof-of-concept phase 2 study. Diabetes Care. 2014 Dec
Title: Hutmacher MM, et al. Exposure-response modeling of average daily pain score, and dizziness and somnolence, forMirogabalin (DS-5565) in patients with diabetic peripheral neuropathic pain. J Clin Pharmacol. 2016 Jan;56(1):67-77.